Cravens & CO Advisors, LLC Pfizer Inc Transaction History

Cravens & CO Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 02, 2024	BUY	$25.89 - $29.73 $43,521 - $49,976	1,681 Added 9.63%	19,135 $531 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $150,456 - $195,426	-5,758 Reduced 24.81%	17,454 $503 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $51,985 - $60,766	1,620 Added 7.5%	23,212 $770 Million
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $1,769 - $2,047	-49 Reduced 0.23%	21,592 $792 Million
Q1 2023 May 26, 2023	SELL	$39.39 - $51.28 $3,426 - $4,461	-87 Reduced 0.4%	21,641 $883 Million
Q4 2022 Feb 24, 2023	BUY	$41.75 - $54.5 $907,144 - $1.18 Million	21,728 New	21,728 $1.11 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cravens & CO Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cravens & CO Advisors, LLC with notifications on news.